FARMACEUTISK LABORATORIUM FERRING A/S: Financial statements 2017
CVR: 62664819
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
FARMACEUTISK LABORATORIUM FERRING A/S (CVR 62664819) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -201,626,000 compared with DKK -2,664,000 the year before. Equity in the 2017 report amounted to DKK -198,623,000.
- Profit/Loss
- DKK -201,626,000
- Equity
- DKK -198,623,000
- Total Assets
- DKK 2,968,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -201.6M | -198.6M | - |
| 2016 | - | - | -2.7M | 3M | - |
| 2015 | - | - | -3.9M | 5.7M | - |
| 2014 | - | - | -2.6M | 3.5M | - |
| 2013 | - | - | -2.5M | 6.1M | - |
Official annual report
Keep an eye on FARMACEUTISK LABORATORIUM FERRING A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
FARMACEUTISK LABORATORIUM FERRING A/S has published its annual report for 2016. The net result was DKK -2,664,000.
About FARMACEUTISK LABORATORIUM FERRING A/S
FARMACEUTISK LABORATORIUM FERRING A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1956. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Marianne Kock. The board consists of Jeffrey Douglas McConaghy (chair), Marianne Kock and Pierre-Jerome Blain. The company is owned by Ferring B.V.. The company has 0 employees (2009). In 2025, the company reported a gross profit of DKK 751,000 and a net result of DKK 100,851,000 compared with DKK -4,904,000 the year before. Equity in the 2025 report amounted to DKK -206,358,000.
